Stockreport

Update: ImmunityBio Gets Approval From Saudi FDA For Non-Muscle Invasive Bladder Cancer Treatment; Shares Rise [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF (Updates with the latest stock movement in the first paragraph and headline.) ImmunityBio (IBRX) [Read more]